← 治験一覧に戻る
大腸がんおよび腺腫の検出における糞便リボ核酸(RNA)検査と便潜血検査(FOBT)の比較
基本情報
- NCT ID
- NCT00197405
- ステータス
- 不明
- 試験のフェーズ
- -
- 試験タイプ
- 観察
- 目標被験者数
- 400
- 治験依頼者名
- Hamamatsu University
概要
Colorectal cancer (CRC) is the second common cause of death in the Western world, and is very increasing in Japan. Fecal occult blood test (FOBT) is used routinely for CRC screening, which has been shown to reduce the incidence, morbidity, and mortality of CRC. However, there is a need to develop a novel method to improve sensitivity. The investigators reported that Fecal COX-2 assay, one of fecal RNA test, is potentially useful for colorectal cancer screening (Gastroenterology 127; 422-427, 2004). So the investigators planed to compare fecal RNA test with FOBT for detecting colorectal cancer and adenoma.
対象疾患
Colorectal Cancer
依頼者(Sponsor)
Hamamatsu University(OTHER)
実施施設 (1)
浜松医科大学医学部附属病院
Hamamatsu, Japan(RECRUITING)